Speaker Profile
Gregory Gregoriadis

Gregory Gregoriadis PhD, DSc

Biotechnology, Clinical Pharmacology, Nanotechnology, Pharmacy and Medicine, Cell and Developmental Biology, Asthma Clinical Immunology, Biochemistry and Molecular Genetics
London, England, United Kingdom

Connect with the speaker?

Professor Gregory Gregoriadis is the Founder (1997) of Xenetic Biosciences Inc and creator of the company's polysialic acid and liposome technologies. He was a Board member, and CSO (1997-2015), Head of the Centre for Drug Delivery Research(1990-2001) at University College London, and Head of the Liposomes Group at the Medical Research Council (1972-1990). In 1971 he introduced (with B. Ryman) liposomes for drug and vaccine delivery and, in 1991, he introduced polysialic acid to improve the pharmacokinetics and pharmacodynamics of protein and peptide drugs.